
Neumann Labs is a diagnostic laboratory specializing in early detection tests for Alzheimer's disease and colorectal cancer through innovative blood-based screening methods. Their key products include the p-tau181 test for Alzheimer's risk assessment and the Colon Ai Q test for colorectal cancer screening. The company differentiates itself with its proactive approach to disease detection, allowing patients to access potential treatments earlier. With a focus on improving patient quality of life, Neumann Labs aims to provide high-accuracy tests that are both cost-effective and non-invasive, positioning itself strongly in the healthcare diagnostics market.

Neumann Labs is a diagnostic laboratory specializing in early detection tests for Alzheimer's disease and colorectal cancer through innovative blood-based screening methods. Their key products include the p-tau181 test for Alzheimer's risk assessment and the Colon Ai Q test for colorectal cancer screening. The company differentiates itself with its proactive approach to disease detection, allowing patients to access potential treatments earlier. With a focus on improving patient quality of life, Neumann Labs aims to provide high-accuracy tests that are both cost-effective and non-invasive, positioning itself strongly in the healthcare diagnostics market.